Back to Newsroom

ISS Recommends Cynapsus Therapeutics Securityholders Vote for the Plan of Arrangement

TORONTO, Sept. 28, 2016 (GLOBE NEWSWIRE) — Cynapsus Therapeutics Inc. (“Cynapsus”) (NASDAQ:CYNA) (TSX:CTH) is pleased to announce today that Institutional Shareholder Services (“ISS”), a leading independent proxy advisory firm, has recommended that Cynapsus shareholders and warrantholders (together, “Securityholders”) vote FOR the special resolution to approve the previously announced plan of arrangement (the “Arrangement”) whereby Sunovion CNS Development Canada ULC, a wholly owned subsidiary of Sunovion Pharmaceuticals Inc., will acquire all of the outstanding common shares and warrants of Cynapsus.  The special resolution will be considered at the upcoming special meeting of Securityholders (the “Meeting”) to be held on October 13, 2016 at 10 a.m. (Toronto time).

Click here to read the full release